Holm Eggemann1, Tanja Ignatov1, Alexander Beni1, Serban Dan Costa1, Atanas Ignatov2. 1. Department of Obstetrics and Gynecology, University Clinic Magdeburg, Magdeburg, Germany. 2. Department of Obstetrics and Gynecology, University Clinic Magdeburg, Magdeburg, Germany; Department of Obstetrics and Gynecology, University Medical Center Regensburg, Regensburg, Germany. Electronic address: atanas.ignatov@gmail.com.
Abstract
INTRODUCTION: The aim of this study was to determine the efficacy of ultrasonography (US)-guided excision of palpable breast cancer and to compare it with the standard palpation-guided breast-conserving surgery (BCS). METHODS: For this purpose, 335 women with palpable breast cancer who underwent BCS were retrospectively studied. The positive surgical margins and re-excision rates were investigated. RESULTS: Of the total cohort, 137 patients were treated with palpation-guided BCS and 198 underwent US-guided tumor excision. The tumor and patient characteristics were similar in both groups. Patient age, postmenopausal status, tumor size, histological grade, intraductal tumor component, lobular histology, and palpation-guided tumor excision were associated with increased risk of positive margins. The shave margins were re-excised at the time of original operation more often by palpation-guided localization (28.5%) than by the US-guided procedure (11.1%) (P < .0001). A surgeon was able to correctly identify the "problematic" margin in 81.1% of cases via intraoperative US and in only 17.9% via palpation (P < .0001). The re-excision rate during a second operation was significantly reduced by US-guided tumorectomy (P = .004). Of 198 patients in the US-guided group, 23 (11.6%) underwent a second operation, as did 33 of 137 patients in the palpation group (24.1%). The sensitivity and specificity of US-guided excisions were 52.7% and 97.5%, respectively, whereas the sensitivity and the specificity of palpation-guided tumor excisions were 15.5% and 65.9%, respectively. CONCLUSION: US-guided BCS is superior to palpation-guided excision in predicting the closest margins, obtaining clear surgical margins, and reducing re-operations.
INTRODUCTION: The aim of this study was to determine the efficacy of ultrasonography (US)-guided excision of palpable breast cancer and to compare it with the standard palpation-guided breast-conserving surgery (BCS). METHODS: For this purpose, 335 women with palpable breast cancer who underwent BCS were retrospectively studied. The positive surgical margins and re-excision rates were investigated. RESULTS: Of the total cohort, 137 patients were treated with palpation-guided BCS and 198 underwent US-guided tumor excision. The tumor and patient characteristics were similar in both groups. Patient age, postmenopausal status, tumor size, histological grade, intraductal tumor component, lobular histology, and palpation-guided tumor excision were associated with increased risk of positive margins. The shave margins were re-excised at the time of original operation more often by palpation-guided localization (28.5%) than by the US-guided procedure (11.1%) (P < .0001). A surgeon was able to correctly identify the "problematic" margin in 81.1% of cases via intraoperative US and in only 17.9% via palpation (P < .0001). The re-excision rate during a second operation was significantly reduced by US-guided tumorectomy (P = .004). Of 198 patients in the US-guided group, 23 (11.6%) underwent a second operation, as did 33 of 137 patients in the palpation group (24.1%). The sensitivity and specificity of US-guided excisions were 52.7% and 97.5%, respectively, whereas the sensitivity and the specificity of palpation-guided tumor excisions were 15.5% and 65.9%, respectively. CONCLUSION: US-guided BCS is superior to palpation-guided excision in predicting the closest margins, obtaining clear surgical margins, and reducing re-operations.
Authors: C Elfgen; B Papassotiropoulos; Z Varga; L Moskovszky; M Nap; U Güth; A Baege; E Amann; F Chiesa; C Tausch Journal: Diagn Pathol Date: 2019-06-15 Impact factor: 2.644
Authors: Jeffery M Chakedis; Annie Tang; Gillian E Kuehner; Brooke Vuong; Liisa L Lyon; Lucinda A Romero; Benjamin M Raber; Melinda M Mortenson; Veronica C Shim; Nicole M Datrice-Hill; Jennifer R McEvoy; Vignesh A Arasu; Dorota J Wisner; Sharon B Chang Journal: Ann Surg Oncol Date: 2021-08-26 Impact factor: 5.344
Authors: Young Duck Shin; Young Jin Choi; Dae Hoon Kim; Sung Su Park; Hanlim Choi; Dong Ju Kim; Sungmin Park; Hyo Yung Yun; Young Jin Song Journal: Medicine (Baltimore) Date: 2017-12 Impact factor: 1.817